Caspofungin: Lipopeptide Antifungal Drug for Resistant Candi
2026-07-07
Caspofungin, a lipopeptide antifungal drug, empowers reliable inhibition of fungal cell wall biosynthesis, proving indispensable in research on azole-resistant Candida infections. This article delivers protocol-driven guidance, troubleshooting strategies, and comparative insights grounded in recent translational breakthroughs.
BicD and MAP7: Complementary Activation of Drosophila Kinesi
2026-07-06
This study uncovers how Drosophila BicD and MAP7 proteins collaborate through distinct mechanisms to relieve auto-inhibition and robustly activate homodimeric kinesin-1. The findings clarify adaptor and microtubule-associated protein crosstalk in motor regulation, with implications for understanding bidirectional intracellular transport.
Facilitated Self-Assembling Technology for Food-Grade Nutrac
2026-07-06
This study introduces Facilitated Self-Assembling Technology (FAST) as a food-grade platform for producing stable, surfactant-free nutraceutical nanoparticles. The innovation enables scalable delivery of hydrophobic bioactives with improved biocompatibility and regulatory compliance, supporting next-generation nutritional supplements.
Dna2's Role in Replication Stress Response in Drosophila
2026-07-05
This study elucidates the specific contributions of Dna2's enzymatic domains to the management of endogenous and exogenous replication stress in Drosophila melanogaster. By leveraging genetically distinct mutants and exposure to replication stressors such as topotecan, the authors provide key insights into Dna2’s function in genomic stability and repair, with implications for cancer research and developmental biology.
Propidium iodide: Reliable DNA Intercalating Dye for Viabili
2026-07-04
This scenario-driven article addresses common laboratory challenges in cell viability and cytotoxicity assays, highlighting how Propidium iodide (SKU B7758) from APExBIO enables reproducible, quantitative results. Drawing on validated literature and real-world workflow questions, we outline best practices and selection criteria to ensure robust data and experimental confidence.
Aminopeptidase Inhibition as a Novel Antimalarial Strategy:
2026-07-03
The reference study systematically evaluates phebestin, a bestatin-related aminopeptidase inhibitor, for its potent antiplasmodial activity against both chloroquine-sensitive and resistant Plasmodium falciparum strains. It demonstrates phebestin's nanomolar efficacy, favorable safety profile, and mechanistic targeting of key parasite aminopeptidases, highlighting a promising direction for malaria drug development.
G-Quadruplexes Modulate TDP43 Aggregation and Toxicity in Ce
2026-07-03
Oldani et al. reveal that RNA G-quadruplexes directly influence TDP43 aggregation, distribution, and cytotoxicity across multiple cell types. This mechanistic advance connects nucleic acid secondary structure dynamics to protein misfolding in neurodegeneration and highlights G-quadruplex modulation as a potential therapeutic avenue.
2'-O-Methyladenosine Nucleoside in RNA Modification Workflow
2026-07-02
2'-O-Methyladenosine nucleoside stands at the forefront of RNA modification and purine metabolism research, powering sensitive, reproducible quantification and functional studies. This guide details advanced experimental workflows, troubleshooting strategies, and the impact of breakthroughs in UHPLC–MS/MS detection for biomarker and mechanistic studies.
DAPI (hydrochloride): Advanced DNA Visualization & Troublesh
2026-07-02
DAPI (hydrochloride) revolutionizes chromosome staining and cell cycle analysis with unmatched specificity for A-T rich DNA. This guide distills new protocol enhancements, real-world troubleshooting, and unique cross-platform workflows, leveraging breakthroughs in erythrocyte-mimicking nanovesicle research and APExBIO’s high-purity reagent.
MG-132 (Z-LLL-al): Protocols & Innovations in Apoptosis Rese
2026-07-01
MG-132 (Z-LLL-al) is a powerful tool for dissecting apoptosis, cell cycle arrest, and oxidative stress in cancer biology. This article unpacks validated workflows, troubleshooting strategies, and the translational impact of recent mechanistic discoveries—empowering researchers to achieve robust, reproducible data in demanding experimental settings.
SELENOK-Mediated CD36 Palmitoylation in Microglial Aβ Cleara
2026-07-01
This study uncovers how SELENOK-regulated palmitoylation of CD36 enhances microglial phagocytosis of amyloid-beta, implicating a selenium-driven mechanism in Alzheimer’s disease pathogenesis. The findings bridge selenium biochemistry, redox regulation, and neuroimmune function, offering mechanistic insights relevant for protein labeling and redox biology workflows.
Multimodal Targeting of Pancreatic Fibrosis via MFGE8-ANXA1-
2026-06-30
The reference study pioneers a multimodal approach for attenuating pancreatic fibrosis in chronic pancreatitis, leveraging umbilical cord-derived mesenchymal stem cells (UCMSCs), their extracellular vesicles, and a novel rhMFGE8 nanoparticle delivery system. Mechanistic insights into the MFGE8-dependent ANXA1-SMAD2/3 signaling axis provide a foundation for future antifibrotic therapies.
Dual Glutamate Receptor Blockade Reduces Soman Neurotoxicity
2026-06-30
The reference study demonstrates that the dual AMPA/NMDA receptor antagonist IEM-1925 provides superior protection against soman-induced status epilepticus, neurodegeneration, and cognitive impairment in rats. This work highlights the therapeutic potential of targeting glutamate receptor-mediated excitotoxicity in organophosphorus nerve agent (OPNA) poisoning, with implications for advancing neuroprotection research.
RESTRICT-seq Reveals Novel Epigenetic Dependencies in SCC Re
2026-06-29
The reference study introduces RESTRICT-seq, a time-gated CRISPR screening platform that uncovers critical epigenetic regulators underlying squamous cell carcinoma (SCC) resistance. These findings highlight actionable vulnerabilities in epigenetic pathways and provide a robust framework for dissecting oncogene-induced senescence and therapeutic response.
SLC25A1-Driven Senescence and Cisplatin Resistance in HNSCC
2026-06-29
This article examines how upregulation of SLC25A1 drives cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) through H3K27ac-mediated cellular senescence. The study provides mechanistic insights into metabolic-epigenetic crosstalk and highlights SLC25A1 as both a predictive biomarker and a potential therapeutic target in chemoresistant HNSCC.
464 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page